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Publicly available molecular datasets can be used for independent veriﬁcation or investigative repurpos-
ing, but depends on the presence, consistency and quality of descriptive annotations. Annotation and
indexing of molecular datasets using well-deﬁned controlled vocabularies or ontologies enables accurate
and systematic data discovery, yet the majority of molecular datasets available through public data
repositories lack such annotations. A number of automated annotation methods have been developed;
however few systematic evaluations of the quality of annotations supplied by application of these meth-
ods have been performed using annotations from standing public data repositories. Here, we compared
manually-assigned Medical Subject Heading (MeSH) annotations associated with experiments by data
submitters in the PRoteomics IDEntiﬁcation (PRIDE) proteomics data repository to automated MeSH
annotations derived through the National Center for Biomedical Ontology Annotator and National Library
of Medicine MetaMap programs. These programs were applied to free-text annotations for experiments
in PRIDE. As many submitted datasets were referenced in publications, we used the manually curated
MeSH annotations of those linked publications in MEDLINE as ‘‘gold standard’’. Annotator and MetaMap
exhibited recall performance 3-fold greater than that of the manual annotations. We connected PRIDE
experiments in a network topology according to shared MeSH annotations and found 373 distinct clus-
ters, many of which were found to be biologically coherent by network analysis. The results of this study
suggest that both Annotator and MetaMap are capable of annotating public molecular datasets with a
quality comparable, and often exceeding, that of the actual data submitters, highlighting a continuous
need to improve and apply automated methods to molecular datasets in public data repositories to max-
imize their value and utility.
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ogies continued to dramatically increase; and due to this, the de-
mand for the sharing of data and results from these technologies
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As a result of these policies, the amount of data in international
repositories has grown exponentially. One such example is NCBI
GEO, an international repository for gene expression data devel-
oped and maintained by the NLM [4]. As of this writing, GEO holds
531,381 samples (i.e., gene expression microarray experiments)
and has been doubling in size every year or two. Similarly, the
ArrayExpress repository maintained by the EBI contains 153,233
independent samples [5]. Recently, international repositories for
proteomic experimental datasets have also been instituted. Pep-
tideAtlas, supported by the Institute for Systems Biology, is an
example of one such repository [6]. As of this writing, PeptideAtlas
holds the raw and processed mass spectra for 366 experiments.
Similarly, the PRIDE database at the EBI currently holds over 13
thousand experiments, 4 million protein identiﬁcations, and 100
million spectra [7].
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data is poor indexing using controlled vocabularies and ontologies
[8,9]. The contents of most of these repositories provide basic
search functionality across the free-text annotations associated
with the data and do not leverage the biomedical knowledge inher-
ent in the annotations. The primary means of data access is typi-
cally the unique identiﬁer assigned to the experiment by the
repository (e.g., GEO accession number), which is typically pro-
vided in publications describing experimental results. But the po-
tential for these and other repositories is more than just serving
as a reference for those who wish to verify and validate published
ﬁndings. We and others have shown that primary research can be
performed using data stored in these repositories [10–14].
GEO, ArrayExpress, PeptideAtlas, and PRIDE are all successful
databases and possess either fully integrated or advance search
interface to retrieve relevant datasets. For example, GEO appears
to be indexed with MeSH and free-text queries are usually trans-
lated to MeSH term searches. PRIDE can be browsed using a variety
of biomedical ontologies but no semantic expansion is performed
on free-text searches. Surprisingly, most repositories, even GEO
or ArrayExpress that are compliant with MIAME and MAGE-ML
standard formats [3,15], do not provide tools to the dataset sub-
mitters to annotate their own submitted data using controlled
vocabularies or ontologies. Consequently, contextual annotations
are still represented by unstructured narrative text and determin-
ing the phenotypes, diseases, and environmental contexts studied
by these experiments is no longer a tractable manual process.
We have previously proposed that the free-text annotations asso-
ciated with experimental datasets can be processed using concept
identiﬁcation programs to yield a high-content set of contextual de-
tails [16]. While it is possible to use automated methods to extract
concepts related to phenotypes, diseases, and drugs studied in an
experiment, it may still be argued that the original dataset submitter
of a dataset might better be able to assign concepts to their data in a
more sensitive and speciﬁc manner than text parsing. Numerous er-
rors in automated concept identiﬁcation from the annotations of
molecular datasets have been described [13]. It has been suggested
that the best long-term strategy to deal with the mapping problem
will be to ask dataset submitters of data to label their own data with
concepts chosen from an ontology relevant to their experimentation.
However, it is not a foregone conclusion that annotations sup-
plied by data submitters will outperform annotations applied to
the same data by automated annotation methods. Annotating free-
text without support of an integrated annotation service is a non-
trivial task and a burden to the submitters that do not necessarily
have the knowledge and/or time to provide high quality annotation
during the submission process. The EBI PRIDE repository, described
above, is unique in that it has asked, but not enforced, dataset sub-
mitters to select and submitMeSH terms alongwith their proteomic
datasets. Thus, in this work, we compared these submitter-assigned
MeSHtermswith the concepts foundbyapplying concept identiﬁca-
tion tools to free-text annotations in PRIDE.
We compared both submitter-assigned and concept-identiﬁed
MeSH against a gold standard consisting of the MeSH terms as-
signed to those MEDLINE publications associated with PRIDE en-
tries. MeSH terms that are later assigned by NLM indexers to
publications are obviously not available earlier to dataset submit-
ters, and we suspect that the terms used by dataset submitters in
the submission of data to EBI PRIDE are not otherwise easily avail-
able or queried by the NLM indexers in annotating publications.
Thus, we feel these annotations are reasonably independent and
can enable a valuable comparison. We compared the output of
two automated concept identiﬁcation methods, the NCBO Annota-
tor [17,18] and the NLM MetaMap [19]. Our goal was to answer
which concept assignment method (manual or automated) is most
accurate, and determine whether dataset submitters are educatedenough about concept-assignment, that their assignments can
sufﬁciently enable the search and integration of datasets.
2. Material and methods
2.1. PRIDE database
We downloaded all 11,694 PRIDE data ﬁles representing 9317
unique PRIDE entries from the EBI FTP server on July 27, 2010. Each
PRIDE entry has several free-text ﬁelds, and we speciﬁcally ex-
tracted the following: ‘‘Title’’, ‘‘ShortLabel’’, ‘‘sampleDescription’’,
‘‘ProtocolName’’, ‘‘sampleName’’ and ‘‘additional’’ (Fig. 1). We also
extracted the PubMed IDs and MeSH terms associated with these
datasets.
2.2. MEDLINE gold standard
Only 2452 PRIDE entries were associated to one or more scien-
tiﬁc publications. Of those we retrieved 88 unique PubMed IDs cor-
responding to publications. Numerous PRIDE entries were
annotated with the same PubMed ID. Through MEDLINE, we re-
trieved overall 298 unique MeSH terms that we associated back
to their respective PRIDE entry to build our gold standard set of
annotations. We used all MEDLINE MeSH terms, and did not focus
just on primary MeSH terms. Trained NLM indexers assign these
MeSH annotations by contrast to PRIDE dataset submitters, who
may not be very familiar with MeSH structure. To test our hypoth-
esis, we also collected the MeSH annotation entered by the dataset
submitter. We found 203 PRIDE entries were annotated with 32
distinct MeSH terms.
2.3. Natural language processing programs
We evaluated the performance of two concept identiﬁcation
software systems on annotating the PRIDE free-text ﬁelds using
MeSH terms. The MetaMap developed by the NLM, represents
the state of the art in automated biomedical text indexing [19].
MetaMap is a well-established software system under develop-
ment and evaluation at the NLM for indexing MEDLINE. MetaMap
indexes free-text with concepts from the Uniﬁed Medical Language
System (UMLS) Metathesaurus. The UMLS contain multiple con-
trolled vocabularies and ontologies such as Gene Ontology,
SNOMED-CT and MeSH. The 2010 release of the program was used.
The NCBO Annotator tool was chosen as a promising newer
alternative to MetaMap, considering its overall higher precision
and faster execution time obtained across different biomedical re-
sources [17,18]. The Annotator service is a Representational State
Transfer (REST)-based web service. Annotator has the capability
of matching free-text against a variety of standardized vocabular-
ies and ontologies, as well as in the UMLS Metathesaurus. In this
study, only the MeSH structure was used to annotate PRIDE en-
tries. Precision (1) and recall (2) for newly mapped annotations
were calculated as follow:
Precision¼ jfMEDLINEMeSH annotationsg\fAutomatedMeSH annotationsgjjfAutomatedMeSH annotationsgj
ð1Þ
Recall¼ jfMEDLINEMeSH annotationsg\fAutomatedMeSH annotationsgjjfMEDLINEMeSH annotationsgj
ð2Þ2.4. Network representation
Annotator annotated 9311 PRIDE entries that grouped into 373
clusters sharing the exact same group of MeSH annotation. We
<ExperimentCollection version="2.1">
<Experiment>
<ExperimentAccession>5</ExperimentAccession>
<Title>HUPO Plasma Proteome Project, Lab # 1 Expt # 37</Title>
<Reference>
<RefLine>Omenn, G.S. (2004) The Human Proteome Organization Plasma Proteome 
Project pilot phase: reference specimens, technology platform comparisons, and standardized data 
submissions and analyses. Proteomics, 4, 1235-1240.</RefLine>
<additional>
<cvParam cvLabel="PubMed" accession="15188391" name="15188391" />
</additional>
</Reference>
[...]
<description>
<admin>
<sampleName>Caucasian-American pooled blood sample, prepared by BD Diagnostics 
(Franklin Lakes, NJ).</sampleName>
<sampleDescription comment="Becton Dickinson (BD) Diagnostics (Franklin Lakes, NJ, 
USA) sets of four reference specimens for each of three ethnic groups: Caucasian-American (b1), 
African-American (b2) and Asian-American (b3).  Each pool consisted of one unit of blood each from 
one male and one post-menopausal female healthy, fasting donor, collected in a standard donor set-up 
after informed consent, and immediately pooled, then divided into four equal volumes in bags with 
appropriate concentrations of K-EDTA, lithium heparin, or sodium citrate for plasma and without clot 
activator for serum.  This procedure required 2 h at room temperature.  Each pool was then aliquoted 
into numerous 250 microliter portions in vials which were then frozen and stored at -70 degrees C.  
Aliquots were tested for HIV, HBV and HCV. We supply sets of 4 x 250 microliter aliquots for each of 
the four plasma/serum specimens.  These vials plus the NIBSC ampoules were shipped frozen on dry 
ice via courier in early May 2003.  Modified from: Gilbert S. Omenn (2004).  The Human Proteome 
Organization Plasma Proteome Project pilot phase:  reference specimens, technology platform 
comparisons and standardized data submissions and analyses.  Proteomics, v.4 n.5 pp.1235-1240.">
[...]
Fig. 1. Example of PRIDE entry raw XML ﬁle displaying the free-text ﬁelds used by NLM MetaMap and NCBO Annotator.
Table 1
Precision and recall obtained using MEDLINE annotation’s gold standard for Anno-
tator and MetaMap programs and original dataset submitter annotations.
Method Precision (%) Recall (%) Annotated
entries (%)
Average MeSH
annotation per entry
Annotator 32.96 1.83 9311 (99.9%) 5.3
MetaMap 35.37 2.45 9315 (99.9%) 8.1
User submitted 97.58 0.59 203 (2.2%) 1.5
Table 2
Comparison of precision and recall of annotations between for Annotator and
MetaMap when considering user submitted MeSH annotation as gold standard.
Method Precision (%) Recall (%)
Annotator 20.97 79.48
MetaMap 15.66 79.44
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annotation between clusters. Clusters were displayed using Cyto-
scape [20]. By setting a threshold over the minimum number of
MeSH terms to be shared between clusters we discovered highly
connected subset of clusters.
3. Results
3.1. Automated annotation results
Using MetaMap and Annotator, we were able to successfully
annotate 9315 and 9311 of the 9317 PRIDE entries, respectively
(Table 1). MetaMap assigned 862 unique MeSH terms compared
to 504 for Annotator. This represents a much greater number than
the current state of MeSH annotations in PRIDE with only 32 differ-
ent concepts over 203 PRIDE entries.
3.2. Precision and recall using MEDLINE gold standard
We compared the precision and recall obtained with MetaMap
and Annotator with the ones obtained by dataset submitter using
our MEDLINE gold standard (Table 1). We found that the precision
achieved by both concept identiﬁcation programs were similarly
high, with scores of 32.96% and 35.37% for Annotator and MetaMap
respectively. Dataset submitters scored almost perfect precision
(97.58%) in tagging their experiments with MeSH concepts. How-
ever, dataset submitters scored very low on recall, at 0.59%. Auto-
mated concept identiﬁcation programs outperformed the recall
from dataset submitters by more than three fold. These results
have to be contrasted with the number of PRIDE entry annotated
by both automated concept identiﬁcation programs reaching
above 99.9% coverage of the entire database compared to only
2.2% for dataset submitters.3.3. User submitted annotation as gold standard
To place the precision and recall from Table 1 in context, we
compared MetaMap and Annotator tagging of PRIDE entries with
MeSH terms assigned by dataset submitters to their own data
(Table 2).
We observed that both MetaMap and Annotator were able to
retrieve most of the dataset submitters MeSH terms with a recall
of 79.44% and 79.48%, respectively. The higher precision observed
for Annotator is most likely explained by MetaMap tagging data-
sets with a much greater number of MeSH terms than Annotator
(see Table 1), which consequently lowered MetaMap precision.
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To further validate the relevance of the annotation retrieved
using automated concept identiﬁcation programs, we displayed
the newly generated annotations in a network. We chose the anno-
tations from the Annotator as a proof-of-concept here; however, an
identical approach can be undertaken using MetaMap annotations.
We found that all 9311 PRIDE IDs annotated using the Annotator
could be grouped into 373 clusters sharing exactly identical sets
of MeSH annotations between them. The largest PRIDE cluster con-
tained 4090 unique PRIDE entries sharing three identical MeSH
terms. All the entries in this cluster belonged to the same project:
‘‘Quantitative Proteomics Analysis of the Secretory Pathway’’. Sim-
ilarly the second largest cluster of 916 PRIDE entries represented
the single project: ‘‘GPMDB Submission: Protein complexes in Sac-
charomyces cerevisiae’’. We then determined the level similarity be-
tween these 373 clusters through the number of shared MeSH
terms between each cluster.
Fig. 2 shows PRIDE clusters having at least 10 MeSH annotations
in common. We found that highly connected clusters are grouped
mainly according to PRIDE projects as well as biological context.
For example, all 95 experiments from the ‘‘HUPO Plasma Proteome
Project’’ were found to share high number of MeSH annotation.
More interestingly, the second cluster represent 25 individual
experiments related to dendritic cells (a sub-type of immune cells
specialized in antigen presenting) but from two different projects.
4. Discussion
Secondary use of the exponentially growing numbers of pub-
licly-available molecular measurements depends on our ability to
discover and identify them within international repositories. We
found that dataset submitters, not otherwise trained speciﬁcally
in standardized vocabularies, can submit relevant MeSH terms.
This ﬁnding is encouraging for public repositories and should en-
gage them in including controlled vocabularies into their submis-
sion workﬂow.
However, while dataset submitters are precise in using terms
that NLM indexers use on their resulting papers, we found that2
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Fig. 2. PRIDE entries clusters sharing 10 or more common MeSH annotation organized
number of PRIDE entries in cluster. Width of the edges is proportional to number of Medataset submitters do not annotate their dataset in great depth,
using on an average only 1.5 MeSH terms per PRIDE experiment,
thus leading to low recall when compared against our MEDLINE
gold standard. This behavior of the data submitters might be ex-
plained in part by the current non-enforcement of the MeSH anno-
tation step in PRIDE and also by the lack of awareness within the
community of the beneﬁt of annotation with standardized terms.
Additionally, ontologies are often large and ﬁnding all relevant
concepts for the experiment at hand can be laborious and time
consuming. Lastly, there are many ontologies that frequently over-
lap and are regularly updated and expanded.
Interestingly, the automated concept identiﬁcation methods we
tested exhibited a higher recall than the dataset submitters in cap-
turing the terms used by NLM indexers, but at the same time, auto-
mated concept identiﬁcation methods demonstrated low precision
against the speciﬁc MeSH terms selected by dataset submitters.
This suggests while dataset submitters actually type in good terms
in the free-text annotations of their datasets, they are not judging
these as relevant enough to put them into their list of MeSH terms.
Future hybrid systems suggesting to dataset submitters several
candidate terms from their own free-text might be an ideal solu-
tion to the annotation problem. Additionally, excluding speciﬁc
categories (also called: semantic types) of MeSH terms, such as
‘‘Geographic Area’’ or ‘‘Professional Society’’, could reduce noise
and increase precision of automated annotations. MetaMap and
Annotator demonstrated an excellent ability to retrieve the dataset
submitter MeSH terms with almost 80% of recall. In our hands,
MetaMap exhibited a lower precision (5%) than Annotator for user
submitted annotation. We do not imply here that one automated
concept identiﬁcation method is better than the other; instead
we used both to ensure our results were not an artifact of one par-
ticular concept identiﬁcation tool. Improvement of the indexing
quality performed by Annotator and MetaMap are possible by tun-
ing the numerous parameters within these programs.
MEDLINE indexing includes a very large spectrum of annota-
tions where not all MeSH terms relevant to the research papers
are also relevant for the associated PRIDE experiments. This could
explain the overall low recall rates for automated and submitter
supplied annotation when using MEDLINE indexing as gold1
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the free-text available through PRIDE the MeSH terms from MED-
LINE. Thus, we are likely underestimating the true recall that could
have been achieved if MEDLINE MeSH annotation could be ﬁltered
for annotation relevant to the PRIDE dataset only. Despite this, we
feel this gold standard serves as a good metric for comparing dif-
ferent methods, since user submitted annotation displayed
97.58% precision indicating that MEDLINE indexers annotate the
published work with the same concept independently from the
dataset submitters. Additionally, MeSH annotations fromMEDLINE
are widely accepted and used throughout the scientiﬁc commu-
nity. We and others have used publication-based MeSH concepts
to annotate and ﬁnd experimental datasets through MEDLINE rela-
tions [21].
Network analysis revealed meaningful annotation of PRIDE en-
tries grouping biologically relevant experiments. Clusters grouping
experiments from the same projects were found predominantly as
they shared almost identical titles, descriptions, sample names and
protocol descriptions.
5. Conclusion
We showed that automated concept identiﬁcation methods
could reach a higher recall ofMeSH annotations than humandataset
submitters who are not speciﬁcally trained in annotating their own
experiments with MeSH concepts. Human submitters achieved the
highest precisionwhen annotating their experiments, but we found
they are also using too few terms to annotate their experiments.
Additionally, we showed that automated concept identiﬁcation pro-
grams could successfullymapproteomic data fromPRIDEgivenonly
the free-text ﬁelds provided by datasets submitters. However, hav-
ing dataset submitters select their own MeSH terms without as-
sisted term selection, does not necessarily add much value beyond
using the MeSH terms provided through MEDLINE or found with
automated concept identiﬁcation programs.
Our results were established numerically and graphically, and
both suggest that our method is a realistic approach to annotating
the PRIDE database, and by extension other molecular databases.
Concept identiﬁcation programs, such as the NLM MetaMap or
NCBO Annotator, are freely available and perhaps could be used
by submitters to scan their abstract for relevant MeSH terms prior
to submission. Enabling dataset submitters to scan their free-text
to attain better MeSH annotations would add little, if any, burden
on the submitters, but could provide an enormous beneﬁt in the
areas of data mining, veriﬁcation of research results, secondary
use of data, and overall accessibility of high-throughput molecular
data to the public.
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